Loading…
NDRI·Addiction Medicine
TGA/PBS — Short-term adjunctive therapy for nicotine dependence in patients committed to quitting, used with counselling
No source link confirmed for this record yet. Its own source notes are under Additional.
Max Dose
300 mg/day
Half-life
21 h
High risk: Seizure Risk
CRITICAL
Sexual Dys.
NONE
Avoid / Cautions
Contraindicated with seizure disorder/history, CNS tumour, current/previous bulimia or anorexia, abrupt alcohol or benzodiazepine withdrawal, MAOI use within 14 days, or hypersensitivity. Reduce dose/frequency in renal or hepatic impairment; severe hepatic cirrhosis max 150 mg every other day.
Overview
A noradrenaline-dopamine reuptake inhibitor approved in Australia as short-term adjunctive therapy for smoking cessation in patients committed to quitting with counselling.
Clinical Focus
Seizure risk is dose-related and patient-factor dependent. Avoid in seizure history, eating disorders, abrupt alcohol/benzodiazepine withdrawal, CNS tumour, and MAOI exposure; keep single doses at 150 mg and daily dose at 300 mg.
Bottom Line
Bupropion SR can help smoking cessation when combined with counselling, but it is a poor fit when seizure threshold is low, eating disorder history is present, alcohol/benzodiazepine withdrawal is likely, or CYP2D6 interactions are clinically important.
Brand Names
Zyban SR, Prexaton
Oral Routes
Modified-release tablet; swallow whole. Do not crush, divide, or chew.
Prescribing & PBS
PBS-listed bupropion hydrochloride 150 mg modified-release tablet items exist for smoking-cessation access; confirm the current item/restriction details before prescribing.
Primary
TGA/PBS — Short-term adjunctive therapy for nicotine dependence in patients committed to quitting, used with counselling.
Off-Label
Off-label note: antidepressant use or antidepressant augmentation is outside the checked Australian PI indication and needs separate source review before being presented as Australian-approved use.
Clinical Place
Excellent for smokers who also have underlying depression or those who fear weight gain upon quitting.
No calculator, monitoring schedule or factsheet is linked to this medicine page yet.